Use of inhibitors of Bruton's tyrosine kinase (Btk)

  • US 10,016,435 B2
  • Filed: 09/26/2017
  • Issued: 07/10/2018
  • Est. Priority Date: 06/03/2010
  • Status: Active Grant
First Claim
Patent Images

1. A method for treating Waldenströ

  • m'"'"'s macroglobulinemia in an individual in need thereof, wherein the individual is treatment-nave for Waldenströ

    m'"'"'s macroglobulinemia, comprising administering to the individual once per day about 420 mg of an oral dose of an inhibitor of Bruton'"'"'s tyrosine kinase (Btk) having the structure;

View all claims

    Thank you for your feedback